Clinical trial
Sleeve Gastrectomy With Jejuno-ileal Bypass Versus Single Anastomosis Sleeve Jejunal Bypass
Recruiting now · Not applicable · 1 countries · Registry ID NCT06530212
Recruiting nowNot applicableInterventional
What this study is about
sleeve gastrectomy with jejunoileal bypass (SGJIB) is a novel technique for the surgical treatment of obesity. The aim of the study is to compare this maneuver with single anastomosis sleeve jejunal bypass (SAS-JB)
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to 65 Years
SexAll
Healthy volunteersNot accepted
ConditionObesity, Morbid
Full registry criteria
Inclusion Criteria: * obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity * patients fit for laparoscopic surgery * give approval to share in the study Exclusion Criteria: * patients refused to share in the study * patients unfit for surgery * patients aged less than 18 and older than 60 * patient with previous upper abdominal surgery either for obesity or other diseases * revisional bariatric procedures
Treatments and study arms
SGJIB
Procedure
sleeve gastrectomy with jejunoileal bypass with anastomosis between the jejunum at about 100 cm from the duodeno-jejunal flexure and the ileum at 250 cm from the ileocaecal junction.
SAS-JB
Procedure
single anastomosis sleeve jejunal bypass (SAS-JB) with biliary limb equal one third of total intestinal length.
Primary outcomes
Stoma complicationsone year
any complication due to sleeve jejunal anastomosis
Study locations
1 locations were listed when this page was built. The first 40 are shown.
Faculty of medicine🇪🇬 Minya, Egypt
Alaa M Sewefy, MDContact
MContact
Alaa Sewefy, professorPrincipal Investigator